Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...

The trade threats could reduce exports to the United States and dampen investment in Europe, dealing a blow to growth at a ...

The start of Donald Trump’s second presidency and Republican control in the 119th Congress raises questions about the future ...

West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...

Indian Prime Minister Narendra Modi has heaped praise on Trump in hopes of avoiding the tariffs that the White House has slapped on other countries.

Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit ...

President Trump’s tariffs in China are in place and hitting all products imported from the country — including a number of pharmaceutical drugs that Americans rely upon. Chinese imports ...

Unlike opium, nitazenes and other synthetic opioids can be produced anywhere in the world using precursor chemicals that are often uncontrolled.

Hospitals and generic drugmakers have join big pharma lobbyists who have said such trade barriers will cause shortages of ...

From the base ingredients to the finished products, US medicines rely on a global supply chain that is already stressed and ...

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic drugs in the United States and exacerbate drug ... generics are sold at low ...